# Perioperative Hemodynamic Monitoring: Art Lines, CVP, PA Catheters, and Non-Invasive CO

## Invasive Arterial Monitoring

### Indications

Invasive arterial monitoring is indicated when significant hemodynamic instability is anticipated (such as cardiac, major vascular, or liver transplant surgery), when frequent arterial blood gas sampling is needed, when non-invasive blood pressure measurement is unreliable (as in morbid obesity, arrhythmias, or prone positioning), and during techniques involving deliberate hypotension or hypertension.

### Cannulation Sites

The **radial artery** is the most commonly used site. A modified Allen test is traditionally performed to confirm dual blood supply to the hand, though its predictive value is debated. The **femoral artery** offers a larger caliber and higher success rate but carries a risk of pseudoaneurysm. The **brachial artery** was historically avoided due to concerns about it being an end artery, though evidence now shows low complication rates. The **dorsalis pedis** artery demonstrates systolic amplification, producing higher systolic and lower diastolic readings compared to central arterial pressures.

### Waveform Interpretation

The arterial waveform contains valuable diagnostic information. The **anacrotic limb** (upstroke) reflects the rate of ventricular ejection. The **dicrotic notch** represents aortic valve closure; its absence suggests severe aortic regurgitation or hypovolemia. **Underdamping** produces an exaggerated waveform with overshoot, overestimating systolic and underestimating diastolic pressure. **Overdamping** produces a flattened waveform that underestimates systolic and overestimates diastolic pressure. The square-wave (fast-flush) test should be performed to assess the dynamic response of the monitoring system.

<image>Detailed medical illustration showing normal arterial waveform with labeled components: anacrotic limb, systolic peak, dicrotic notch, and diastolic runoff. Alongside, two abnormal waveforms demonstrating underdamped (ringing oscillations) and overdamped (blunted peak) tracings with a fast-flush square wave test for each.</image>

## Central Venous Pressure (CVP)

### Waveform Components

The CVP waveform contains five identifiable components. The **a wave** represents atrial contraction and is absent in atrial fibrillation. The **c wave** corresponds to tricuspid valve closure and isovolumetric ventricular contraction. The **x descent** reflects atrial relaxation. The **v wave** represents passive atrial filling against the closed tricuspid valve. The **y descent** occurs with tricuspid valve opening and passive ventricular filling.

### Pathologic Patterns

Abnormal CVP waveform patterns provide important diagnostic information. **Giant a waves (cannon a waves)** occur with AV dissociation, complete heart block, or junctional rhythm, when the atrium contracts against a closed tricuspid valve. **Large v waves** indicate tricuspid regurgitation. An **absent x descent** also suggests tricuspid regurgitation. A **steep y descent** is characteristic of constrictive pericarditis or restrictive cardiomyopathy. **Absent a waves** confirm atrial fibrillation.

### CVP as a Measure of Volume Status

CVP is a poor predictor of fluid responsiveness, as its correlation with preload is weak. The CVP value is influenced by right ventricular compliance, intrathoracic pressure, and tricuspid valve function, all of which confound its interpretation as a volume indicator. Trends in CVP may be somewhat more useful than absolute values. CVP should not be used in isolation to guide fluid management decisions.

<image>Medical diagram showing the CVP waveform tracing with labeled a, c, x, v, and y components aligned with the ECG above it. Below, three pathological CVP waveforms are shown: cannon a waves in complete heart block, giant v waves in tricuspid regurgitation, and the steep y descent of constrictive pericarditis.</image>

## Pulmonary Artery (Swan-Ganz) Catheter

### Measured vs. Derived Parameters

The PA catheter directly measures several hemodynamic parameters: CVP (right atrial pressure), right ventricular pressures, pulmonary artery pressures, pulmonary capillary wedge pressure (PCWP), cardiac output via thermodilution, and mixed venous oxygen saturation (SvO2). From these measurements, several parameters are derived: systemic and pulmonary vascular resistance, cardiac index, stroke volume, oxygen delivery (DO2), and oxygen consumption (VO2).

### Indications (Debated)

The indications for PA catheter placement are debated but generally include severe LV dysfunction (EF below 25-30%) undergoing major surgery, pulmonary hypertension management, complex valvular disease, liver and cardiac transplantation, and distinguishing between cardiogenic and non-cardiogenic pulmonary edema.

### Complications

PA catheter placement carries several risks. Arrhythmias, particularly premature ventricular contractions during passage through the right ventricle, are common but typically self-limited. Pulmonary artery rupture is rare but potentially fatal, with risk increased by pulmonary hypertension, anticoagulation, and hypothermia. Persistent catheter wedging can cause pulmonary infarction. Other complications include catheter knotting, infection, and thrombosis.

### The PA Catheter Debate

Multiple randomized controlled trials, including PAC-Man, ESCAPE, and FACTT, have failed to demonstrate a mortality benefit from PA catheter use. Consequently, its use has declined dramatically since the 2000s. The catheter may still provide value in specific populations, particularly cardiac surgery patients and those with severe pulmonary hypertension. Operator skill and protocol-driven interpretation of the data remain key determinants of whether the information translates into improved outcomes.

## Dynamic Predictors of Fluid Responsiveness

### Pulse Pressure Variation (PPV)

Pulse pressure variation is calculated as the difference between maximum and minimum pulse pressures divided by the mean pulse pressure over a respiratory cycle. A PPV greater than 13% predicts fluid responsiveness with high sensitivity and specificity. Valid measurement requires mechanical ventilation with tidal volumes of at least 8 mL/kg, sinus rhythm, and a closed chest.

### Stroke Volume Variation (SVV)

Stroke volume variation applies the same respiratory-induced variation principle to stroke volume rather than pulse pressure. An SVV greater than 12-13% suggests the patient will respond to fluid administration. This parameter is available on several monitoring platforms including FloTrac/Vigileo, LiDCO, and PiCCO systems.

### Limitations of Dynamic Parameters

Dynamic parameters become invalid during spontaneous breathing, with low tidal volumes, during open-chest surgery, and in the presence of arrhythmias. Right heart failure may produce false-positive results, and PEEP levels above 10 cmH2O may affect accuracy.

### Other Functional Tests

The **passive leg raise (PLR)** test auto-transfuses approximately 300 mL of blood by elevating both legs; an increase in cardiac output greater than 10% predicts fluid responsiveness. Its greatest advantage is that it works during spontaneous breathing and in patients with arrhythmias. The **end-expiratory occlusion test** involves a 15-second breath hold; an increase in cardiac output greater than 5% is a positive result. A **mini-fluid challenge** uses a rapid 100 mL bolus with monitoring for changes in velocity time integral (VTI) or cardiac output.

<image>Clinical infographic comparing static versus dynamic predictors of fluid responsiveness. On the left, a column showing static parameters (CVP, PCWP) with low predictive accuracy. On the right, dynamic parameters (PPV, SVV, passive leg raise) with higher predictive accuracy. Each parameter has conditions listed for valid use and threshold values for positive response.</image>

## Non-Invasive Cardiac Output Monitoring

### Pulse Contour Analysis (Calibrated)

Calibrated pulse contour systems use an initial calibration measurement to improve accuracy. The **PiCCO** system uses transpulmonary thermodilution for calibration and then provides continuous cardiac output via pulse contour analysis. The **LiDCO** system uses lithium dilution for calibration followed by pulse power analysis. Both require recalibration after significant hemodynamic changes.

### Pulse Contour Analysis (Uncalibrated)

The **FloTrac/Vigileo** system uses the arterial waveform combined with patient demographics to estimate cardiac output without external calibration. It is less accurate during rapid hemodynamic changes, vasoplegia, or high-dose vasopressor use.

### Esophageal Doppler

The esophageal Doppler measures blood flow velocity in the descending thoracic aorta, providing estimates of stroke volume, corrected flow time (FTc), and cardiac output. It has shown particular utility in goal-directed fluid therapy for colorectal and orthopedic surgery.

### Bioimpedance / Bioreactance

Non-invasive thoracic electrodes estimate cardiac output from changes in electrical impedance across the chest. These systems are less accurate than invasive methods but can be useful for trending changes over time.

| Monitoring Device | Invasiveness | Calibration | Key Measurements | Best Use Scenario |
|---|---|---|---|---|
| PA catheter | High (central venous + PA) | Thermodilution | CO, PCWP, SvO2, SVR, PVR | Severe LV dysfunction, pulmonary HTN, cardiac surgery |
| PiCCO | Moderate (arterial + CVC) | Transpulmonary thermodilution | CO, SVV, GEDV, EVLW | Major surgery, sepsis; requires recalibration |
| LiDCO | Moderate (arterial + peripheral IV) | Lithium dilution | CO, SVV, PPV | Major surgery; lithium dose concern |
| FloTrac/Vigileo | Low (arterial line only) | Uncalibrated | CO, SVV, SVR | General OR monitoring; less accurate in vasoplegia |
| Esophageal Doppler | Low (esophageal probe) | None (velocity-based) | SV, FTc, CO | Goal-directed fluid therapy |
| Bioimpedance/Bioreactance | Non-invasive (skin electrodes) | None | CO (trending) | Low-risk surgery, trending |
| Focused TTE | Non-invasive (probe on chest) | None | LVOT VTI, qualitative function | Rapid bedside assessment |

### Focused Transthoracic Echocardiography

Measurement of the left ventricular outflow tract velocity time integral (LVOT VTI) combined with LVOT diameter provides a non-invasive calculation of cardiac output. Beyond cardiac output, focused TTE also assesses ventricular filling, contractility, valvular function, and pericardial effusion.

<image>Comparison chart of cardiac output monitoring devices arranged from most invasive (PA catheter, left) to least invasive (bioreactance, right). Each device is illustrated with its placement location, key measurements provided, accuracy level, and ideal clinical scenarios for use. Includes PiCCO, FloTrac, esophageal Doppler, and focused TTE.</image>

## Clinical Pearls

The fast-flush (square wave) test should be performed at the start of every case using an arterial line to verify appropriate dynamic response. MAP is the most reliable pressure from the arterial waveform because it is least affected by damping and distal amplification. A sudden loss of the dicrotic notch or decreased pulse pressure may be the earliest sign of hypovolemia or cardiac tamponade. The passive leg raise is the most versatile test for fluid responsiveness because it works in spontaneously breathing patients and those with arrhythmias. When in doubt about CVP interpretation, the waveform morphology provides more diagnostic information than the absolute number. PA catheter data is only useful if the clinician can correctly interpret wedge tracings and understand the clinical context in which they are obtained.

## References

- Saugel B, Vincent JL. Cardiac output monitoring: how to choose the optimal method for the individual patient. *Current Opinion in Critical Care*. 2018;24(3):165-172.
- Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. *Critical Care Medicine*. 2013;41(7):1774-1781.
- Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. *Chest*. 2002;121(6):2000-2008.
- Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. *New England Journal of Medicine*. 2003;348(1):5-14.
- ASA Practice Guidelines for Pulmonary Artery Catheterization. *Anesthesiology*. 2003;99(4):988-1014.